Market Research Reports
Resources
About
Cart (0)

Brain Tumor Drugs Global Market Report 2023

Publish Date: Feb 2023

Report Code: TBR604E

Publisher: TBRC (Publisher)

Download Report Overview

Single User License: $5000

Explore Our Services

Already a member? Login here.

Report Highlights

Including: 1) By Type: Medulloblastoma; Astrocytoma; Oligodendroglioma; Primitive Neuroectodermal (PNET)
2) By Drugs: Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib
3) By End User: Hospital Pharmacies; Clinics
Covering: Pfizer Inc.; Shimadzu Corporation; Toshiba Medical Systems; Merck & Co. Inc.; AstraZeneca

Brain Tumor Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on brain tumor drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for brain tumor drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The brain tumor drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2032
Units considered $ Billion
Segments covered By Type, By Drugs, By End User
Industry covered Pharmaceuticals
Regions covered Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.
Companies studied
  • Pfizer Inc.;
  • AbbVie;
  • Shimadzu Corporation;
  • Toshiba Medical Systems;
  • Merck & Co. Inc.;
  • AstraZeneca;
  • Carestream Health;
  • Philips Healthcare;
  • Siemens Healthineers;
  • Hitachi Medical Corporation;
  • GE Healthcare;
  • Novartis AG;
  • Bristol-Myers Squibb;
  • Antisense Pharma;
  • Astellas Pharma;
  • Roche;
  • Celgene
  • Johnson & Johnson;
  • Genetech U.S.A;
  • Hoffmann- La Roche;
  • Dr. Reddys Laboratories Ltd.
  • Macleods Pharmaceutical Limited;
  • Mankind Pharma;

Scope

Markets Covered:

  • By Type: Medulloblastoma; Astrocytoma; Oligodendroglioma; Primitive Neuroectodermal (PNET); Others (Glioma, Acoustic Neuroma, Meningioma)
  • By Drugs: Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib
  • By End User: Hospital Pharmacies; Clinics; Other End-Users

Companies Mentioned: Pfizer Inc.; Shimadzu Corporation; Toshiba Medical Systems; Merck & Co. Inc.; AstraZeneca

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

  • Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3 : Global Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4 : Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5 : Global Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6 : Global Brain Tumor Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7 : Global Brain Tumor Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8 : Asia-Pacific, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9 : Asia-Pacific, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10 : China, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11 : China, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12 : India, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13 : India, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14 : Japan, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15 : Japan, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16 : Australia, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17 : Australia, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18 : Indonesia, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19 : Indonesia, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20 : South Korea, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21 : South Korea, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22 : Western Europe, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23 : Western Europe, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24 : UK, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25 : UK, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26 : Germany, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27 : Germany, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28 : France, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29 : France, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30 : Eastern Europe, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31 : Eastern Europe, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32 : Russia, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33 : Russia, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34 : North America, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35 : North America, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36 : USA, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37 : USA, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38 : South America, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39 : South America, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40 : Brazil, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41 : Brazil, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42 : Middle East, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43 : Middle East, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44 : Africa, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45 : Africa, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46 : Pfizer Inc. Financial Performance
  • Table 47 : Shimadzu Corporation Financial Performance
  • Table 48 : Toshiba Medical Systems Financial Performance
  • Table 49 : Merck & Co. Inc. Financial Performance
  • Table 50 : AstraZeneca Financial Performance
  • Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3 : Global Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4 : Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5 : Global Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6 : Global Brain Tumor Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7 : Global Brain Tumor Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8 : Asia-Pacific, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9 : Asia-Pacific, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10 : China, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11 : China, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12 : India, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13 : India, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14 : Japan, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15 : Japan, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16 : Australia, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17 : Australia, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18 : Indonesia, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19 : Indonesia, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20 : South Korea, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21 : South Korea, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22 : Western Europe, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23 : Western Europe, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24 : UK, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25 : UK, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26 : Germany, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27 : Germany, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28 : France, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29 : France, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30 : Eastern Europe, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31 : Eastern Europe, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32 : Russia, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33 : Russia, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34 : North America, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35 : North America, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36 : USA, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37 : USA, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38 : South America, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39 : South America, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40 : Brazil, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41 : Brazil, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42 : Middle East, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43 : Middle East, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44 : Africa, Brain Tumor Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45 : Africa, Brain Tumor Drugs Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46 : Pfizer Inc. Financial Performance
  • Figure 47 : Shimadzu Corporation Financial Performance
  • Figure 48 : Toshiba Medical Systems Financial Performance
  • Figure 49 : Merck & Co. Inc. Financial Performance
  • Figure 50 : AstraZeneca Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Brain Tumor Drugs Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR604D

Including: 1) By Type: Medulloblastoma; Astrocytoma; Oligodendroglioma; Primitive Neuroectodermal (PNET); Others (Glioma, Acoustic Neuroma, Meningioma)
2) By Drugs: Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib
3) By End User: Hospital Pharmacies; Clinics; Others
Covering: Pfizer Inc.; Shimadzu Corporation; Toshiba Medical Systems; Merck & Co. Inc.; AstraZeneca; Carestream Health; Philips Healthcare

Brain Tumor Drugs Global Market Report 2022 from The Business ...

Brain Tumor Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery

  • Date - Feb 2022
  • Code - TBR604C

Including: 1) By Drugs: Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib
2) By End User: Hospital Pharmacies; Clinics; Others
Covering: F. Hoffmann-La Roche Ltd.; Novartis AG; Amgen Inc.; Pfizer Inc.; Merck & Co. Inc.; CordenPharm; Eisai Co., Ltd.

Brain Tumor Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery from The Business Research Company provides the strategists; ...

Brain Tumor Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • Date - Apr 2021
  • Code - TBR604B

Including: 1) By Drugs: Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib
2) By End User: Hospital Pharmacies; Clinics; Others
Covering: Pfizer Inc.; Shimadzu Corporation; Toshiba Medical Systems; Merck & Co. Inc.; AstraZeneca

Brain Tumor Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical ...

Brain Tumor Drugs Global Market Report 2020

  • Date - Dec 2019
  • Code - TBR604A

Including: 1) By Drugs: Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib 2) By End User: Hospital Pharmacies, Clinics, Others
Covering: Pfizer Inc., Shimadzu Corporation, Toshiba Medical Systems, Merck & Co. Inc., AstraZeneca

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Brain Tumor Drugs Global Market Report 2023
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2024 BCC Research
Privacy Policy |Site Map|Terms & Conditions